Kennedy Lewis Investment Management proposes to buy Rapid Micro Biosystems for $5/share
176.64MUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US75340L1044
CUSIP
75340L104
Sector
Healthcare
Industry
Medical Devices
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
1.50
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.03
Wall Street Target Price
8.00
EPS Estimate Current Year
-0.99
EPS Estimate Next Year
-0.88
EPS Estimate Current Quarter
-0.27
EPS Estimate Next Quarter
-0.27
Most Recent Quarter
-
Revenue TTM
29,645,000
Gross Profit TTM
1,818,000
EBITDA
-44,304,000
Profit Margin
-151.22%
Return On Assets TTM
-27.74%
Return On Equity TTM
-52.30%
Revenue Per Share TTM
0.677
Qtly Revenue Growth YOY
28.40%
Diluted Eps TTM
-1.03
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
5.9586
Price Book MRQ
2.6972
Enterprise Value Revenue
4
Enterprise Value EBITDA
0
26.01
9.07%56.90
5.32%79.20
4.64%89.15
2.68%403.98
1.76%26.16
1.26%28.04
1.08%92.94
0.63%126.34
0.52%106.40
0.17%